Washington Trust Bank’s Pfizer PFE Stock Holding History

Washington Trust Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	16,728 -1,000	-6%	-$26.2K	0.03%	163
2026 Q1	$498K	Buy	17,728 +1,000	+6%	+$26.6K	0.04%	137
2025 Q4	$417K	Sell	16,728 -1	-0%	-$25	0.03%	151
2025 Q3	$426K	Buy	16,729 +798	+5%	+$19.7K	0.03%	147
2025 Q2	$386K	Sell	15,931 -8,993	-36%	-$210K	0.03%	155
2025 Q1	$632K	Sell	24,924 -629	-2%	-$16.5K	0.06%	117
2024 Q4	$678K	Sell	25,553 -1,622	-6%	-$44K	0.07%	121
2024 Q3	$786K	Buy	27,175 +783	+3%	+$22.8K	0.08%	108
2024 Q2	$738K	Sell	26,392 -2,659	-9%	-$73.2K	0.07%	104
2024 Q1	$806K	Sell	29,051 -4,548	-14%	-$126K	0.08%	107
2023 Q4	$967K	Sell	33,599 -3,744	-10%	-$113K	0.09%	101
2023 Q3	$1.24M	Buy	37,343 +253	+0.7%	+$8.95K	0.13%	86
2023 Q2	$1.36M	Sell	37,090 -3,459	-9%	-$135K	0.14%	82
2023 Q1	$1.65M	Sell	40,549 -5,219	-11%	-$225K	0.18%	78
2022 Q4	$2.35M	Sell	45,768 -1,549	-3%	-$74.3K	0.27%	73
2022 Q3	$2.07M	Buy	47,317 +3,013	+7%	+$146K	0.26%	76
2022 Q2	$2.32M	Buy	44,304 +714	+2%	+$36.4K	0.3%	69
2022 Q1	$2.26M	Sell	43,590 -8,704	-17%	-$452K	0.26%	68
2021 Q4	$3.09M	Buy	52,294 +414	+0.8%	+$20.5K	0.3%	61
2021 Q3	$2.23M	Buy	51,880 +7,285	+16%	+$323K	0.26%	60
2021 Q2	$1.75M	Buy	44,595 +495	+1%	+$19.2K	0.21%	69
2021 Q1	$1.6M	Buy	44,100 +3,311	+8%	+$118K	0.2%	75
2020 Q4	$1.5M	Sell	40,789 -3,471	-8%	-$127K	0.2%	74
2020 Q3	$1.54M	Sell	44,260 -1,895	-4%	-$66.4K	0.23%	66
2020 Q2	$1.43M	Sell	46,155 -86	-0.2%	-$2.92K	0.23%	68
2020 Q1	$1.43M	Buy	46,241 +2,302	+5%	+$78.4K	0.27%	57
2019 Q4	$1.63M	Sell	43,939 -1,147	-3%	-$40.9K	0.23%	79
2019 Q3	$1.54M	Sell	45,086 -1,507	-3%	-$54.8K	0.25%	72
2019 Q2	$1.92M	Sell	46,593 -1,078	-2%	-$42.8K	0.31%	64
2019 Q1	$1.92M	Sell	47,671 -5,921	-11%	-$237K	0.31%	66
2018 Q4	$2.22M	Sell	53,592 -5,108	-9%	-$212K	0.29%	72
2018 Q3	$2.45M	Sell	58,700 -10,603	-15%	-$408K	0.36%	59
2018 Q2	$2.38M	Buy	69,303 +1,268	+2%	+$43.3K	0.33%	62
2018 Q1	$2.29M	Sell	68,035 -2,415	-3%	-$83K	0.33%	60
2017 Q4	$2.42M	Buy	70,450 +2,153	+3%	+$73.4K	0.35%	58
2017 Q3	$2.31M	Buy	68,297 +14,488	+27%	+$466K	0.37%	58
2017 Q2	$1.72M	Buy	53,809 +398	+0.7%	+$12.6K	0.37%	59
2017 Q1	$1.73M	Sell	53,411 -918	-2%	-$28.9K	0.37%	59
2016 Q4	$1.67M	Buy	54,329 +690	+1%	+$21.1K	0.38%	58
2016 Q3	$1.72M	Buy	53,639 +4,524	+9%	+$151K	0.41%	54
2016 Q2	$1.64M	Sell	49,115 -5,162	-10%	-$165K	0.42%	52
2016 Q1	$1.53M	Buy	54,277 +4,972	+10%	+$142K	0.39%	50
2015 Q4	$1.51M	Buy	49,305 +452	+0.9%	+$14.2K	0.33%	59
2015 Q3	$1.46M	Sell	48,853 -2,015	-4%	-$64.6K	0.39%	57
2015 Q2	$1.62M	Buy	50,868 +2,972	+6%	+$96.9K	0.39%	53
2015 Q1	$1.58M	Sell	47,896 -159	-0.3%	-$5.05K	0.38%	58
2014 Q4	$1.42M	Buy	48,055 +1,645	+4%	+$47.2K	0.37%	68
2014 Q3	$1.3M	Sell	46,410 -25,510	-35%	-$716K	0.41%	62
2014 Q2	$2.02M	Buy	71,920 +5,270	+8%	+$150K	0.41%	65
2014 Q1	$2.03M	Buy	+66,650	New	+$1.99M	0.43%	64
2013 Q4	–	Sell	-38,799	Closed	-$1.13M	–	4
2013 Q3	$1.06M	Buy	38,799 +1,407	+4%	+$38.3K	0.28%	82
2013 Q2	$993K	Buy	+37,392	New	+$1.03M	0.29%	84

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Washington Trust Bank's PFE Position: Q2 2026 in Review

Washington Trust Bank reduced its Pfizer (PFE) stake by 5.6% in Q2 2026, selling an estimated $26.2K and leaving 16,728 shares worth $403K. The position accounts for 0.03% of the portfolio, ranked #163.

Washington Trust Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.09M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Washington Trust Bank held 16,728 shares of Pfizer worth $403K as of Q2 2026.
Washington Trust Bank sold 1,000 Pfizer shares in Q2 2026, an estimated $26.2K.
Pfizer made up 0.03% of Washington Trust Bank's portfolio in Q2 2026, its #163 holding.
Washington Trust Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Washington Trust Bank's Pfizer position peaked at $3.09M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Washington Trust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.